Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesMolecular ImagingSNMMI: New molecular imaging agent shows promise for detecting HCCA new molecular imaging agent has shown high sensitivity and specificity in detecting hepatocellular carcinoma (HCC).Molecular ImagingSNMMI: PET imaging improves OMD detection in breast cancer patientsMolecular ImagingSNMMI: F-18 FDS PET distinguishes molds in invasive fungal infectionsMolecular ImagingSNMMI: New immuno-PET tracer awarded Image of the YearSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!
